InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the full record of transactions filed by Orlinger Klaus, Vice-Président Exécutif, Recherche. Director active across 1 company, notably HOOKIPA Pharma Inc.. Aggregated, 1 disclosures have been recorded. History available since 1 February 2022. The latest transaction was filed on 1 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Orlinger Klaus is Executive Vice President of Research at Hookipa Pharma Inc. In this role, he oversees the company's research and development operations. His expertise in the pharmaceutical sector enables him to effectively lead research and innovation teams. He plays a key role in developing new products and guiding Hookipa Pharma's strategic direction.